| P50 | author | Antonio Llombart-Bosch | Q45924296 |
| | Karin Jirström | Q29077282 |
| P2093 | author name string | Fritz Rank | |
| | Julio E Celis | |
| | Pavel Gromov | |
| | Antonio Llombart-Bosch | |
| | Irina Gromova | |
| | José M A Moreira | |
| | Teresa Cabezón | |
| | Vera Timmermans-Wielenga | |
| | Esbern Friis | |
| P2860 | cites work | Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast | Q46620153 |
| | Invasive apocrine carcinoma of the breast: clinicopathologic features of 57 patients | Q46773052 |
| | Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer | Q46789030 |
| | Apocrine cysts of the breast: biomarkers, origin, enlargement, and relation with cancer phenotype. | Q46827099 |
| | Palpable right breast mass in a pregnant woman. | Q51833996 |
| | Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ. | Q54630457 |
| | Hormone receptor profile of apocrine lesions of the breast. | Q54656221 |
| | GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland | Q24649647 |
| | Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels | Q27860531 |
| | Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications | Q27860709 |
| | Molecular portraits of human breast tumours | Q28032461 |
| | Repeated observation of breast tumor subtypes in independent gene expression data sets | Q28131820 |
| | Prostaglandins and cancer | Q28188827 |
| | Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up | Q28306437 |
| | High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss | Q28343524 |
| | Molecular cytogenetic comparison of apocrine hyperplasia and apocrine carcinoma of the breast | Q28345661 |
| | Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world | Q29614969 |
| | Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery | Q31039477 |
| | Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation | Q34573593 |
| | Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease. | Q34977042 |
| | Loss of heterozygosity in fibrocystic change of the breast: genetic relationship between benign proliferative lesions and associated carcinomas | Q35745924 |
| | Advances in the biology of lung cancer chemoprevention | Q36123308 |
| | Non-operative breast pathology: apocrine lesions | Q36172494 |
| | Statins and their roles in cancer | Q36219360 |
| | Molecular pathology of breast apocrine carcinomas: a protein expression signature specific for benign apocrine metaplasia. | Q36456638 |
| | Immunohistochemical localisation of androgen receptor in apocrine metaplasia and apocrine adenosis of the breast: relation to oestrogen and progesterone receptors | Q37242122 |
| | Apocrine mammary carcinoma. A clinicopathologic study of 72 cases | Q37895492 |
| | Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies. | Q38451314 |
| | Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres. | Q38453048 |
| | Breast macrocysts | Q38768125 |
| | 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer | Q40248466 |
| | Down-regulation of the tumor suppressor protein 14-3-3sigma is a sporadic event in cancer of the breast. | Q40472812 |
| | Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia | Q41251750 |
| | Identification of molecular apocrine breast tumours by microarray analysis. | Q42478400 |
| | Recent trends in cancer survival across Europe between 2000 and 2004: a model-based period analysis from 12 cancer registries | Q43596226 |
| | Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers | Q43623312 |
| P433 | issue | 10 | |
| P304 | page(s) | 1795-1809 | |
| P577 | publication date | 2008-07-16 | |
| P1433 | published in | Molecular & Cellular Proteomics | Q6895932 |
| P1476 | title | 15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma. | |
| P478 | volume | 7 | |